# A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus

> **NCT01789788** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 56 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO6811135

## Key facts

- **NCT ID:** NCT01789788
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01789788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01789788, "A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01789788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*